Trial Information
Summary: Alprostadil in Macular Degeneration Study (AIMS)
Confirmatory, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Assess the Efficacy and Safety of Prostaglandin E-1 in Subjects With Dry Age-Related Macular Degeneration.
Evaluation of efficacy of alprostadil for treatment of patients suffering from age-related macula degeneration
Inclusion Criteria:
- macular degeneration with hard drusen and with beginning geographic atrophy in one eye
- Male and female subjects older than 50 years of age.
Exclusion Criteria:
- Glaucoma
- Diabetic retinopathy
- Uveitis
- Medical history of any ophthalmic surgery with complications
- Medical history of cataract surgery without complications
- Medical history of vitrectomy
- AREDS medication
- Ophthalmologic dietary supplements
- Medical history of retinal hemorrhage
- Cardiac failure (NYHA grade II or higher)
- Inadequately controlled coronary heart disease or cardiac arrhythmia
- Subject has a medical history and/or suspicion of pulmonary edema or pulmonary infiltration
- Subject has a peripheral edema
- Myocardial infarction within 6 months prior to enrollment
- Subject has renal insufficiency, compensated retention (creatinine > 1.5mg/dL)
- Subject has known existing malignant disease
- Severe chronic obstructive pulmonary disease
- Subject has a veno-occlusive lung disease
- Known hepatic disease
- Inadequately controlled or untreated hypertension (systolic blood pressure = 180mmHg, diastolic blood pressure =110 mmHg
- Subject has upper grade cardiac valvular disorders
- Pregnancy or lactation period
- Known hypersensitivity to Prostaglandin E-1 (PGE-1) or to any component of the trial medication
- Subject has a history of chronic alcohol or drug abuse within the past 2 years
- Subject has known lactose intolerance
- Poor general state of health or other criteria
|
Contact:
UCB Clinical Trial Call Center
Located in:
Siegburg, Germany,
Telephone: +1-877-822-9493
|
|
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:43:20 AM
